Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
We recommend checking for board certifications, experience with weight management, and real patient reviews before choosing a provider
However, you must consult your healthcare provider before stopping to ensure alternative diabetes management is in place and to prevent blood glucose deterioration
The short version is that retatrutide is not just trying to suppress appetite
Can it be sold for research
As Dr Sullivan commented, the benefit appears to increase over time rather than fade, and that it behaves like a drug in terms of dose response. Dr Sullivan and colleagues concluded that these results support DMR as a promising, procedure-based strategy to maintain weight loss and potentially enable shorter-duration GLP-1 therapy. In a press release, Dr Sullivan noted, Finding a treatment that allows patients to stop [GLP-1] medications without weight regain or loss of metabolic benefit is a huge unmet need. She continued, These findings indicate that this minimally invasive procedure may provide lasting weight-loss maintenance. Six-month cohort data from the REMAIN-1 trial are expected to be reported late in 2026.
